Oral dosage forms have always been the backbone of the pharmaceutical industry. Still, no matter how effective these oral dosages are in the lab, they only work if patients actually take them. This obvious statement is the defining concept of healthcare today – patient centricity.
Film-coated tablets are the foundation of this approach. In this blog, we have explained why tablet manufacturers worldwide believe that these pharmaceutical tablet coatings represent the future of oral dosage forms. To understand this, let us know what lies in the future of oral dosage forms.
The future of pharma is patient centricity.
Patient centricity is designing healthcare around the real needs, preferences, and experiences of patients, rather than just the convenience of manufacturers, prescribers, or systems. This means that pharma manufacturers are shifting away from mass production of generic tablets to making tablets that patients prefer.
How tablet coating solutions support patient centricity?
Many people assume that film-coated pills are just for cosmetic purposes. But on the contrary, film coating has become a defining factor in making oral medicines more patient-centric, safe, and effective.
Overcoming phagophobia:
Phagophobia is the fear of the act of swallowing itself. And you may not believe, but it is more common than we think. Film-coated pills are smoother, reducing friction and making them easier to swallow. This is particularly important for pediatric and geriatric patients who may struggle with uncoated tablets.
Making medicine more palatable:
Many APIs are bitter, metallic, or have an unpleasant odor. For patients, this can be a dealbreaker. Tablet coating formulations, such as Novomix, mask unpleasant tastes and smells, making tablets more acceptable.
Making oral dosages safer:
Have you heard of someone experiencing stomach pain or nausea after taking medicines? Some medicines even lead to GI bleeding. While intended to cure, such medicines backfire. With enteric coating, the drug bypasses the stomach, reducing irritation and improving tolerability.
Maximum effect in minimal doses:
Pharmaceutical tablet coating controls how a drug is released. For example, enteric coating are designed to prevent dissolution in the acidic environment of the stomach, ensuring the drug is released in the intestine. Extended-release drugs are designed for slow release over time. This ensures that the patients get a consistent therapeutic effect even with fewer doses.
Burden to a relief:
Multiple dosing schedule often confuses patients and cause non-adherence. Modified-release coating allows drugs to be taken once a day instead of multiple times. Also, for people who juggle multiple medicines, cues from the tablet film coatings help with easy identification. Hence, the chances of patients sticking to their regimes are much higher.
Playing with perception:
A tablet’s look and feel shape patient trust. A smooth, professional-looking film-coated pill feels safer and more “medical” than a rough, crumbly one. So often, tablets coated with Novomix film coating translate into adherence.
Bridging the Gap Between Lab Efficacy and Real-World Patient Use
Pharma tablet coating determines whether oral dosages work in real-life patient scenarios or merely in laboratory settings. And when we say work for real-life patients, it means they are not only practical but also easy to take, safe, and acceptable for patients.
The future of oral dosage forms is even more promising with advancements in increased drug absorption and extended release of drugs.
Conclusion:
For many patients, large or rough tablets used to be a hard-to-swallow pill, both literally and figuratively. With modern Novomix pharmaceutical tablet coating, that statement may no longer hold. Because of the specialised film coating, the tablets are now easier to swallow, more tolerable, and more likely to be taken consistently.
The next-gen of oral dosage forms lies with coating that don’t just protect the drug, but also the patient experience. Novo excipients, a leading tablet film coating manufacturer, offers advanced, customised solutions that support next-gen tablets. Our expert team relies on practical innovation to solve formulation needs, regulatory standards, and patient compliance.
THINK COATING THINK NOVO